Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2013-07-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome
NCT03064464
Hospital Acquired and Community Acquired MRSA in GI Lab
NCT00577343
Antibiotics Resistance Gene in Healthcare Workers
NCT06228248
Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
NCT04312776
Stop Community MRSA Colonization Among Patients
NCT02029872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FMT treatment
Treat the patients by fecal microbiota transplantation
Fecal microbiota transplantation
bacteria liquid from 60g fecal was infusion via nasointestinal tube for three days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fecal microbiota transplantation
bacteria liquid from 60g fecal was infusion via nasointestinal tube for three days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jinling Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
weiyao
Institute of General Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ning Li, MD
Role: STUDY_DIRECTOR
Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University，
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRSA-FMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.